-
公开(公告)号:EP4233854A2
公开(公告)日:2023-08-30
申请号:EP23174724.7
申请日:2020-10-29
发明人: HEPLER, Douglas I. , DEMPSEY, Gail L. , JOHNSON, Roland , KELLY, Michael , DANIEL, Michael , PAULSEN, Neil E. , CLAYTON, Bert
IPC分类号: A61K31/192
摘要: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
-
公开(公告)号:EP4233854A3
公开(公告)日:2024-01-17
申请号:EP23174724.7
申请日:2020-10-29
发明人: HEPLER, Douglas I. , DEMPSEY, Gail L. , JOHNSON, Roland , KELLY, Michael , DANIEL, Michael , PAULSEN, Neil E. , CLAYTON, Bert
IPC分类号: A61K9/00 , A61K9/08 , A61K9/20 , A61K47/10 , A61K47/12 , A61K31/352 , A61K31/485 , A61P29/00
摘要: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
-
公开(公告)号:EP4034099A1
公开(公告)日:2022-08-03
申请号:EP20879964.3
申请日:2020-10-23
IPC分类号: A61K31/341 , A61K31/501 , A61K31/55
-
-